Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Life Science Membrane Technology Market Size, Share, and Forecast, 2026-2033 | Bioprocessing and Scalable Purification Drive Growth to USD 8.9 Billion

globenewswire.com
RGEN Repligen Corporation is listed as a company in the life science membrane technology market. The article discusses market trends and growth drivers, but does not provide specific sentiment or performance details for Repligen. FMS Fresenius Medical Care AG is identified as a company within the life science membrane technology market. The article focuses on market size, trends, and segmentation, without offering specific sentiment or performance analysis for the company.

Global Life Science Membrane Technology Market Size, Share, and Forecast, 2026-2033 | Bioprocessing and Scalable Purification Drive Growth to USD 8.9 Billion Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Life Science Membrane Technology Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global life science membrane technology market was valued at USD 6.0 billion in 2025 and is projected to expand from USD 6.3 billion in 2026 to USD 8.9 billion by 2033. The market is expected to register a CAGR of 5.1% from 2026 to 2033, supported by the growing adoption of membrane-based bioprocessing and continued advances in biopharmaceutical manufacturing.

Demand for efficient, scalable separation and purification technologies is increasing across pharmaceutical production, biologics manufacturing, diagnostics, medical devices, laboratory research, and water purification. The expansion of bioprocessing capacity, rising biologics development, and greater use of flexible manufacturing platforms are expected to create additional opportunities for membrane technology suppliers.

North America led the global life science membrane technology market with a revenue share of 35.6% in 2025. The region's position reflects its established biopharmaceutical sector, substantial research activity, advanced healthcare infrastructure, and ongoing investment in pharmaceutical and biotechnology manufacturing. The report also assesses growth prospects across Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA).

Market Segmentation and Forecast Coverage

The report provides revenue forecasts and trend analysis for the period from 2021 to 2033. It evaluates the market by technology, material, application, product type, end use, and region, enabling stakeholders to identify high-potential segments and assess changing industry requirements.

Technology Segments

Material Segments

Application Segments

Product Type Segments

End Use Segments

Regional Market Analysis

Regional coverage includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). Country-level analysis encompasses the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, Thailand, South Korea, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.

Strategic Value of the Report

The report delivers market intelligence designed to support investment planning, product development, competitive positioning, and commercial strategy. Detailed revenue estimates help organizations compare opportunities across technologies, materials, applications, product categories, end users, and geographic markets.

By combining market forecasts, competitive analysis, trend assessment, and regional insights, the report supports biopharma companies, pharmaceutical manufacturers, CDMOs & CROs, research institutions, hospitals, clinical laboratories, investors, and technology providers seeking to navigate the expanding global life science membrane technology market.

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.1.1. Segment Definitions

1.1.1.1. Technology Segment

1.1.1.2. Material Segment

1.1.1.3. Application Segment

1.1.1.4. Product Type Segment

1.1.1.5. End-use Segment

1.2. Regional Scope

1.3. Estimates and Forecast Timeline

1.4. Objectives

1.5. Research Methodology

1.6. Information Procurement

1.6.1. Purchased Database

1.6.2. The internal database

1.6.3. Secondary Sources

1.6.4. Primary Research

1.7. Information or Data Analysis:

1.7.1. Data Analysis Models

1.8. Market Formulation & Validation

1.9. Model Details

1.9.1. Commodity Flow Analysis

1.9.2. List of Secondary Sources

1.9.3. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Growing Demand for Efficient Separation and Purification Technologies

3.2.1.2. Increasing Adoption of Membrane-Based Bioprocessing

3.2.1.3. Expansion of Cell and Gene Therapy Manufacturing

3.2.2. Market Restraint Analysis

3.2.2.1. High Capital and Operating Costs

3.2.2.2. Stringent Regulatory and Validation Requirements

3.2.3. Market Opportunities Analysis

3.2.4. Market Challenges Analysis

3.3. Industry Analysis Tools

3.3.1. Porter's Five Forces Analysis

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTLE Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Social landscape

3.3.2.4. Economic landscape

3.3.2.5. Legal landscape

Chapter 4. Technology Business Analysis

4.1. Segment Dashboard

4.2. Life Science Membrane Technology Market: Technology Movement Analysis

4.3. Microfiltration

4.3.1. Microfiltration Market, 2021-2033 (USD Million)

4.4. Ultrafiltration

4.4.1. Ultrafiltration Market, 2021-2033 (USD Million)

4.5. Nanofiltration

4.5.1. Nanofiltration Market, 2021-2033 (USD Million)

4.6. Reverse Osmosis

4.6.1. Reverse Osmosis Market, 2021-2033 (USD Million)

4.7. Chromatography & Affinity Membranes

4.7.1. Chromatography & Affinity Membranes Market, 2021-2033 (USD Million)

4.8. Electrodialysis & Ion Exchange

4.8.1. Electrodialysis & Ion Exchange Market, 2021-2033 (USD Million)

Chapter 5. Material Business Analysis

5.1. Segment Dashboard

5.2. Life Science Membrane Technology Market: Material Movement Analysis

5.3. Polymeric

5.3.1. Polymeric Market, 2021-2033 (USD Million)

5.4. Ceramic

5.4.1. Ceramic Market, 2021-2033 (USD Million)

5.5. Mixed-Matrix / Hybrid

5.5.1. Mixed-Matrix / Hybrid Market, 2021-2033 (USD Million)

Chapter 6. Application Business Analysis

6.1. Segment Dashboard

6.2. Life Science Membrane Technology Market: Application Movement Analysis

6.3. Pharmaceutical Manufacturing

6.3.1. Pharmaceutical Manufacturing Market, 2021-2033 (USD Million)

6.4. Bioprocessing & Biologics

6.4.1. Bioprocessing & Biologics Market, 2021-2033 (USD Million)

6.5. Medical Devices & Dialysis

6.5.1. Medical Devices & Dialysis Market, 2021-2033 (USD Million)

6.6. Diagnostics & Life-science Research

6.6.1. Diagnostics & Life-science Research Market, 2021-2033 (USD Million)

6.7. Laboratory Water Purification

6.7.1. Laboratory Water Purification Market, 2021-2033 (USD Million)

Chapter 7. Product Type Business Analysis

7.1. Segment Dashboard

7.2. Life Science Membrane Technology Market: Product Type Movement Analysis

7.3. Membrane Filters (Flat-Sheet, Disc)

7.3.1. Membrane Filters (Flat-Sheet, Disc) Market, 2021-2033 (USD Million)

7.4. Capsule / Cartridge Filters

7.4.1. Capsule / Cartridge Filters Market, 2021-2033 (USD Million)

7.5. Hollow-Fiber Modules

7.5.1. Hollow-Fiber Modules Market, 2021-2033 (USD Million)

7.6. Single-Use TFF Systems

7.6.1. Single-Use TFF Systems Market, 2021-2033 (USD Million)

7.7. Transfer / Blotting Membranes

7.7.1. Transfer / Blotting Membranes Market, 2021-2033 (USD Million)

Chapter 8. End-use Business Analysis

8.1. Segment Dashboard

8.2. Life Science Membrane Technology Market: End-use Movement Analysis

8.3. Biopharma Companies

8.3.1. Biopharma Companies Market, 2021-2033 (USD Million)

8.4. Pharmaceutical Companies

8.4.1. Pharmaceutical Companies Market, 2021-2033 (USD Million)

8.5. CDMOs & CROs

8.5.1. CDMOs & CROs Market, 2021-2033 (USD Million)

8.6. Academic & Research Institutes

8.6.1. Academic & Research Institutes Market, 2021-2033 (USD Million)

8.7. Hospitals & Clinical Labs

8.7.1. Hospitals & Clinical Labs Market, 2021-2033 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Life Science Membrane Technology Market Share by Region, 2025 & 2033

9.2. North America

9.2.1. North America Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.2.2. U.S.

9.2.2.1. Key Country Dynamics

9.2.2.2. Competitive Scenario

9.2.2.3. Regulatory Framework

9.2.2.4. U.S. Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.2.3. Canada

9.2.3.1. Key Country Dynamics

9.2.3.2. Competitive Scenario

9.2.3.3. Regulatory Framework

9.2.3.4. Canada Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.2.4. Mexico

9.2.4.1. Key Country Dynamics

9.2.4.2. Competitive Scenario

9.2.4.3. Regulatory Framework

9.2.4.4. Mexico Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3. Europe

9.3.1. Europe Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.2. UK

9.3.2.1. Key Country Dynamics

9.3.2.2. Competitive Scenario

9.3.2.3. Regulatory Framework

9.3.2.4. UK Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.3. Germany

9.3.3.1. Key Country Dynamics

9.3.3.2. Competitive Scenario

9.3.3.3. Regulatory Framework

9.3.3.4. Germany Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.4. France

9.3.4.1. Key Country Dynamics

9.3.4.2. Competitive Scenario

9.3.4.3. Regulatory Framework

9.3.4.4. France Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.5. Italy

9.3.5.1. Key Country Dynamics

9.3.5.2. Competitive Scenario

9.3.5.3. Regulatory Framework

9.3.5.4. Italy Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.6. Spain

9.3.6.1. Key Country Dynamics

9.3.6.2. Competitive Scenario

9.3.6.3. Regulatory Framework

9.3.6.4. Spain Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.7. Denmark

9.3.7.1. Key Country Dynamics

9.3.7.2. Competitive Scenario

9.3.7.3. Regulatory Framework

9.3.7.4. Denmark Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.8. Sweden

9.3.8.1. Key Country Dynamics

9.3.8.2. Competitive Scenario

9.3.8.3. Regulatory Framework

9.3.8.4. Sweden Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.3.9. Norway

9.3.9.1. Key Country Dynamics

9.3.9.2. Competitive Scenario

9.3.9.3. Regulatory Framework

9.3.9.4. Norway Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4. Asia Pacific

9.4.1. Asia Pacific Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.2. Japan

9.4.2.1. Key Country Dynamics

9.4.2.2. Competitive Scenario

9.4.2.3. Regulatory Framework

9.4.2.4. Japan Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.3. China

9.4.3.1. Key Country Dynamics

9.4.3.2. Competitive Scenario

9.4.3.3. Regulatory Framework

9.4.3.4. China Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.4. India

9.4.4.1. Key Country Dynamics

9.4.4.2. Competitive Scenario

9.4.4.3. Regulatory Framework

9.4.4.4. India Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.5. Australia

9.4.5.1. Key Country Dynamics

9.4.5.2. Competitive Scenario

9.4.5.3. Regulatory Framework

9.4.5.4. Australia Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.6. Thailand

9.4.6.1. Key Country Dynamics

9.4.6.2. Competitive Scenario

9.4.6.3. Regulatory Framework

9.4.6.4. Thailand Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.4.7. South Korea

9.4.7.1. Key Country Dynamics

9.4.7.2. Competitive Scenario

9.4.7.3. Regulatory Framework

9.4.7.4. South Korea Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.5. Latin America

9.5.1. Latin America Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.5.2. Brazil

9.5.2.1. Key Country Dynamics

9.5.2.2. Competitive Scenario

9.5.2.3. Regulatory Framework

9.5.2.4. Brazil Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.5.3. Argentina

9.5.3.1. Key Country Dynamics

9.5.3.2. Competitive Scenario

9.5.3.3. Regulatory Framework

9.5.3.4. Argentina Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.6. MEA

9.6.1. MEA Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.6.2. South Africa

9.6.2.1. Key Country Dynamics

9.6.2.2. Competitive Scenario

9.6.2.3. Regulatory Framework

9.6.2.4. South Africa Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.6.3. Saudi Arabia

9.6.3.1. Key Country Dynamics

9.6.3.2. Competitive Scenario

9.6.3.3. Regulatory Framework

9.6.3.4. Saudi Arabia Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.6.4. UAE

9.6.4.1. Key Country Dynamics

9.6.4.2. Competitive Scenario

9.6.4.3. Regulatory Framework

9.6.4.4. UAE Life Science Membrane Technology Market, 2021-2033 (USD Million)

9.6.5. Kuwait

9.6.5.1. Key Country Dynamics

9.6.5.2. Competitive Scenario

9.6.5.3. Regulatory Framework

9.6.5.4. Kuwait Life Science Membrane Technology Market, 2021-2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization

10.2. Company Market Share/ Position Analysis, 2025

10.3. Strategy Mapping

10.4. Company Profiles/Listing

10.4.1. Sartorius AG

10.4.1.1. Overview

10.4.1.2. Financial Performance

10.4.1.3. Product Benchmarking

10.4.1.4. Strategic Initiatives

10.4.2. Merck KGaA

10.4.2.1. Overview

10.4.2.2. Financial Performance

10.4.2.3. Product Benchmarking

10.4.2.4. Strategic Initiatives

10.4.3. Danaher Corporation

10.4.3.1. Overview

10.4.3.2. Financial Performance

10.4.3.3. Product Benchmarking

10.4.3.4. Strategic Initiatives

10.4.4. Repligen Corporation

10.4.4.1. Overview

10.4.4.2. Financial Performance

10.4.4.3. Product Benchmarking

10.4.4.4. Strategic Initiatives

10.4.5. Asahi Kasei Corporation

10.4.5.1. Overview

10.4.5.2. Financial Performance

10.4.5.3. Product Benchmarking

10.4.5.4. Strategic Initiatives

10.4.6. TORAY INDUSTRIES, INC.

10.4.6.1. Overview

10.4.6.2. Financial Performance

10.4.6.3. Product Benchmarking

10.4.6.4. Strategic Initiatives

10.4.7. Kovalus Separation Solutions (Acquired by Sun Capital Partners, Inc.)

10.4.7.1. Overview

10.4.7.2. Financial Performance

10.4.7.3. Product Benchmarking

10.4.7.4. Strategic Initiatives

10.4.8. MANN+HUMMEL

10.4.8.1. Overview

10.4.8.2. Financial Performance

10.4.8.3. Product Benchmarking

10.4.8.4. Strategic Initiatives

10.4.9. NIPRO

10.4.9.1. Overview

10.4.9.2. Financial Performance

10.4.9.3. Product Benchmarking

10.4.9.4. Strategic Initiatives

10.4.10. Fresenius Medical Care AG

10.4.10.1. Overview

10.4.10.2. Financial Performance

10.4.10.3. Product Benchmarking

10.4.10.4. Strategic Initiatives

10.4.11. GVS S.p.A.

10.4.11.1. Overview

10.4.11.2. Financial Performance

10.4.11.3. Product Benchmarking

10.4.11.4. Strategic Initiatives

List of Tables [153]

List of Figures [77]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/b8f95l

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.